- Home
- GROW vs HBIO Comparison
GROW vs HBIO Comparison
Compare GROW & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | HBIO |
|---|---|---|
| Founded | 1968 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 33.8M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | GROW | HBIO |
|---|---|---|
| Price | $2.42 | $0.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 43.8K | ★ 928.6K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $8,546,000.00 | ★ $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.22 |
| P/E Ratio | $36.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.02 | $0.28 |
| 52 Week High | $2.78 | $2.28 |
Technical Indicators
Market Signals| Indicator | GROW | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 60.77 |
| Support Level | $2.33 | $0.68 |
| Resistance Level | $2.50 | $0.84 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 47.12 | 60.45 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.